Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Cidara Therapeutics, Inc. (CDTX) had Free Cash Flow per Share of $-3.84 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-83.23M |
|
-- |
|
-- |
|
$88.63M |
|
$-88.63M |
|
$5.39M |
|
$-83.23M |
|
$-83.23M |
|
$-83.23M |
|
$-83.23M |
|
$-83.23M |
|
$-83.23M |
|
$-88.63M |
|
$-88.77M |
|
26.88M |
|
26.88M |
|
$-3.10 |
|
$-3.10 |
|
| Balance Sheet Financials | |
$442.82M |
|
$0.29M |
|
$75.83M |
|
$518.65M |
|
$95.84M |
|
-- |
|
$0.42M |
|
$96.26M |
|
$422.39M |
|
$422.39M |
|
$422.39M |
|
29.34M |
|
| Cash Flow Statement Financials | |
$-103.53M |
|
$-176.28M |
|
$383.62M |
|
$196.18M |
|
$299.99M |
|
$103.81M |
|
$7.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-103.34M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.71% |
|
-19.71% |
|
-16.05% |
|
-19.71% |
|
$14.40 |
|
|
Free Cash Flow per Share |
$-3.84 |
$-3.85 |
|